title: ESPRIT in context: pharmacology matters!
authors.forename: J E
authors.initials: JE
authors.lastname: Tcheng
authors.forename: J
authors.initials: J
authors.lastname: Strony
authors.forename: T J
authors.initials: TJ
authors.lastname: Lorenz
authors.forename: J C
authors.initials: JC
authors.lastname: O'Shea
mesh_terms: D000077284:Abciximab; D017130:Angioplasty / Q000379:methods; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D000077542:Eptifibatide; D006207:Half-Life; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D000077466:Tirofiban; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D014443:Tyrosine; D000077466:Tirofiban; D000077542:Eptifibatide; D000077284:Abciximab